Illumina Inc
NASDAQ:ILMN
Relative Value
The Relative Value of one ILMN stock under the Base Case scenario is 166.47 USD. Compared to the current market price of 124.41 USD, Illumina Inc is Undervalued by 25%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ILMN Competitors Multiples
Illumina Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Illumina Inc
NASDAQ:ILMN
|
19.8B USD | 4.4 | -17 | 56.9 | -266.6 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
220.6B USD | 5.2 | 36.8 | 22.9 | 33.6 | ||
US |
Danaher Corp
NYSE:DHR
|
180.9B USD | 4.2 | 22.4 | 16.5 | 20.3 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD | 2.8 | 30.5 | 16.9 | 26.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.3 | 31.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.2T KRW | 14.9 | 64.3 | 33.9 | 48.8 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 5.6 | 56.5 | 19.7 | 28.9 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7.1 | 33.8 | 23.8 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9.1 | 46.7 | 32.4 | 39.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
24.9B USD | 3 | 36.5 | 16.5 | 25.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.1B EUR | 7.1 | 75.2 | 32.3 | 53 |